Next Article in Journal
Release of Terpenes from Fir Wood during Its Long-Term Use and in Thermal Treatment
Next Article in Special Issue
Computational Prediction of Blood-Brain Barrier Permeability Using Decision Tree Induction
Previous Article in Journal
Design and Synthesis of a Series of Pyrido[2,3-d]pyrimidine Derivatives as CCR4 Antagonists
Previous Article in Special Issue
Hologram QSAR Models of 4-[(Diethylamino)methyl]-phenol Inhibitors of Acetyl/Butyrylcholinesterase Enzymes as Potential Anti-Alzheimer Agents

BCL::EMAS — Enantioselective Molecular Asymmetry Descriptor for 3D-QSAR

Department of Chemistry, Pharmacology, and Biomedical Informatics, Center for Structural Biology, Institute of Chemical Biology, Vanderbilt University, Nashville, TN 37232-6600, USA
Author to whom correspondence should be addressed.
Molecules 2012, 17(8), 9971-9989;
Received: 29 June 2012 / Revised: 15 August 2012 / Accepted: 15 August 2012 / Published: 20 August 2012
(This article belongs to the Special Issue QSAR and Its Applications)
Stereochemistry is an important determinant of a molecule’s biological activity. Stereoisomers can have different degrees of efficacy or even opposing effects when interacting with a target protein. Stereochemistry is a molecular property difficult to represent in 2D-QSAR as it is an inherently three-dimensional phenomenon. A major drawback of most proposed descriptors for 3D-QSAR that encode stereochemistry is that they require a heuristic for defining all stereocenters and rank-ordering its substituents. Here we propose a novel 3D-QSAR descriptor termed Enantioselective Molecular ASymmetry (EMAS) that is capable of distinguishing between enantiomers in the absence of such heuristics. The descriptor aims to measure the deviation from an overall symmetric shape of the molecule. A radial-distribution function (RDF) determines a signed volume of tetrahedrons of all triplets of atoms and the molecule center. The descriptor can be enriched with atom-centric properties such as partial charge. This descriptor showed good predictability when tested with a dataset of thirty-one steroids commonly used to benchmark stereochemistry descriptors (r2 = 0.89, q2 = 0.78). Additionally, EMAS improved enrichment of 4.38 versus 3.94 without EMAS in a simulated virtual high-throughput screening (vHTS) for inhibitors and substrates of cytochrome P450 (PUBCHEM AID891). View Full-Text
Keywords: QSAR; CADD; stereochemistry; enantiomer; molecular asymmetry; chirality QSAR; CADD; stereochemistry; enantiomer; molecular asymmetry; chirality
Show Figures

Figure 1

MDPI and ACS Style

Sliwoski, G.; Lowe, E.W., Jr.; Butkiewicz, M.; Meiler, J. BCL::EMAS — Enantioselective Molecular Asymmetry Descriptor for 3D-QSAR. Molecules 2012, 17, 9971-9989.

AMA Style

Sliwoski G, Lowe EW Jr., Butkiewicz M, Meiler J. BCL::EMAS — Enantioselective Molecular Asymmetry Descriptor for 3D-QSAR. Molecules. 2012; 17(8):9971-9989.

Chicago/Turabian Style

Sliwoski, Gregory, Edward W. Lowe Jr., Mariusz Butkiewicz, and Jens Meiler. 2012. "BCL::EMAS — Enantioselective Molecular Asymmetry Descriptor for 3D-QSAR" Molecules 17, no. 8: 9971-9989.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop